0001654954-18-010573.txt : 20180927
0001654954-18-010573.hdr.sgml : 20180927
20180927183232
ACCESSION NUMBER: 0001654954-18-010573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180809
FILED AS OF DATE: 20180927
DATE AS OF CHANGE: 20180927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mazar Andrew Paul
CENTRAL INDEX KEY: 0001727393
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55866
FILM NUMBER: 181092145
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD
STREET 2: SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 5 REVERE DRIVE, SUITE 200
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
BUSINESS PHONE: 6143958936
MAIL ADDRESS:
STREET 1: 5 REVERE DRIVE, SUITE 200
CITY: NORTHBROOK
STATE: IL
ZIP: 60062
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2018-08-09
0001645469
Monopar Therapeutics
NONE
0001727393
Mazar Andrew Paul
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
true
true
true
Chief Scientific Officer
Common stock
14002.8
D
Common stock
4111272.88
I
See Footnote (1)
Common stock
166667
I
See Footnote (2)
Stock options
6
2018-08-09
4
A
false
134300
0
A
2019-04-01
2028-08-08
Common stock
134300
134300
D
This is based upon the 4,111,272.88 shares of Monopar Common Stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Dr. Mazar may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Dr. Mazar disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
This is based upon the 166,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Dr. Mazar may be deemed to share voting and dispositive power over these 166,667 shares. Dr. Mazar disclaims beneficial ownership of the 166,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein.
Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter.
/s/ Kim R. Tsuchimoto, Attorney in fact
2018-09-27